Oncology News and Research

RSS

Oncology, meaning bulk, mass, or tumor, and the suffix ''-logy'', meaning "study of") is a branch of medicine that deals with tumors (cancer). A medical professional who practices oncology is an ''oncologist''.

Inhibitor Education Summits to address pertinent topics regarding hemophilia

More than 160 families of patients living with a rare form of hemophilia are coming together at educational summits sponsored this fall by the National Hemophilia Foundation (NHF) and the Center for Biomedical Continuing Education (CBCE). For the fifth year, the Inhibitor Education Summits will connect patients and their families with expert healthcare professionals and fellow patients to address pertinent topics such as effective pain management, exercise and nutrition, financial security, and psychological wellbeing.

29 Aug 2009

Research round-up: Highlights from recent releases

American Health Care Association (AHCA): State-by-State Medicare Cuts to Nursing Homes -- "A new [AHCA] analysis of the pending House health reform bill [HR 3200], combined with the impact of a recently-enacted Medicare regulation cutting Medicare-funded nursing home care by $12 billion over ten years, finds seniors in fifteen states requiring nursing and rehabilitative care will face total funding cuts in excess of $1 billion over that same time period," according to an AHCA description of the study. "The assessment was based on the Congressional Budget Office (CBO) score of both HR 3200 and the recent CMS funding rule, along with Medicare Skilled Nursing Facility (SNF) utilization data." A breakdown of each of the 15 states facing ten-year billion dollar cuts to Medicare-funded nursing homes is available online (8/20).

28 Aug 2009

Facet Biotech And Trubion to jointly develop and commercialize the TRU-016 SMIP protein therapeutic

Facet Biotech Corporation (Nasdaq: FACT) and Trubion Pharmaceuticals, Inc. (Nasdaq: TRBN) today announced an agreement for the joint worldwide development and commercialization of TRU-016, a product candidate in phase 1 clinical development for chronic lymphocytic leukemia (CLL).

28 Aug 2009

Ipsen Group announces first-half 2009 financial results

The Board of Directors of Ipsen (Paris:IPN), chaired by Jean-Luc Bélingard, met on 27 August 2009 to review the Group’s results for the first half 2009, published today. The full 2009 half year financial report is available on the Group’s web site, www.ipsen.com, under the Regulated Information heading in the Investor Relations pages.

28 Aug 2009

TRAF6 protein can activate a cell signalling molecule associated with cancer

The mainstay immune system protein TRAF6 plays an unexpected, key role activating a cell signaling molecule that in mutant form is associated with cancer growth, researchers at The University of Texas M. D. Anderson Cancer Center report in the Aug. 28 edition of Science.

28 Aug 2009

Springer signs agreement with The Endocrine Society to co-publish a new journal

Springer, one of the leading publishers in the fields of science, technology and medicine, has signed an agreement with The Endocrine Society to co-publish a new journal, Hormones & Cancer, starting in January 2010.

28 Aug 2009

Gen-Probe commences its PROGENSA PCA3 assay clinical trial

Gen-Probe Incorporated announced today that the Company has begun a clinical trial intended to secure U.S. regulatory approval of its PROGENSA(R) PCA3 assay, a new molecular test that may help determine the need for a repeat prostate biopsy.

28 Aug 2009

Abbott to partner with Pfizer to develop a companion diagnostic test for non-small cell lung cancer

Abbott announced today that it has entered into an agreement with Pfizer Inc to develop a molecular diagnostic test intended to screen non-small cell lung cancer (NSCLC) tumors for the presence of gene rearrangements.

28 Aug 2009

Dr. David J. Caparrelli becomes a member of SVS at its Vascular Annual Meeting

Dr. David J. Caparrelli who practices at Arizona Heart Institute (AHI) became an active member of the Society for Vascular Surgery (SVS) during its Vascular Annual Meeting in Denver.

28 Aug 2009

$11.5 million grant to Mayo Clinic Cancer Center to translate research into treatments for women with ovarian cancer

Investigators at the Mayo Clinic Cancer Center have received a five-year, $11.5 million grant to translate research into treatments for women with ovarian cancer.

28 Aug 2009

Novel methodology developed to extract microRNAs from cancer tissues

Researchers led by Dr. Soheil Dadras at the Stanford University Medical Center have developed a novel methodology to extract microRNAs from cancer tissues. The related report by Ma et al, "Profiling and discovery of novel miRNAs from formalin-fixed paraffin-embedded melanoma and nodal specimens," appears in the September 2009 issue of the Journal of Molecular Diagnostics.

28 Aug 2009

Gen-Probe commences clinical study to secure U.S. approval of the PROGENSA PCA3 assay

DiagnoCure Inc. (TSX: CUR) announced that Gen-Probe, Inc. (NASDAQ: GPRO), its partner for the development and commercialization of the PCA3 prostate cancer test, has confirmed today the beginning of a U.S. clinical study intended to secure U.S. regulatory approval of the PROGENSA(R) PCA3 assay, a new molecular test that may help determine the need for a repeat prostate biopsy.

28 Aug 2009

Champions Biotechnology reports higher year-on-year operating revenues for fiscal year 2009

Champions Biotechnology, Inc. (OTC Bulletin Board: CSBR), a company engaged in the development of advanced preclinical platforms and tumor specific data to enhance the value of oncology drugs, today announced its financial results for the fiscal year ended April 30, 2009. Full details of the Company's financial results are available in the Company's Form 10-K available at www.championsbiotechnology.com.

28 Aug 2009

Chk1 and Fbx6 play an important role for the regulation of response to chemotherapy

Cell cycle checkpoints act like molecular tripwires for damaged cells, forcing them to pause and take stock. Leave the tripwire in place for too long, though, and cancer cells will press on regardless, making them resistant to the lethal effects of certain types of chemotherapy, according to researchers at the Salk Institute for Biological Studies.

28 Aug 2009

Arno Therapeutics to commence Phase 1 clinical study of AR-12 in adult patients with lymphoma

Arno Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on oncology therapeutics, today announced the dosing of the first patient in a Phase I clinical study of AR-12 (formerly OSU-03012) in adult patients with advanced or recurrent solid tumors or lymphoma.

28 Aug 2009

Resonant Medical's multi-anatomy Clarity System to be exhibited at ESTRO, Netherlands

Resonant Medical, an innovator in soft tissue planning, image-guidance and adaptive radiotherapy products, today announced that the Company will be exhibiting the next generation of its multi-anatomy Clarity System at the 10th Biennial Meeting of The European Society of Therapeutic Radiology and Oncologists (ESTRO), being held in Maastricht, Netherlands.

27 Aug 2009

Adventist Medical Center receives the Community Value Index Five-Star hospital award

Adventist Medical Center (AMC) has received the Community Value Index (CVI) Five-Star hospital award for the third consecutive year. Developed by Cleverley and Associates, the national recognition signifies AMC’s dedication to meeting the healthcare needs of the community in a financially responsible, efficient and effective manner.

27 Aug 2009

Bioreference Laboratories to issue earnings results for Q3 Fiscal Year 2009

BioReference Laboratories, Inc. announced today it plans to issue earnings results for the third quarter of fiscal 2009 before the open of market trading on Wednesday, September 2, 2009.

27 Aug 2009

Researchers devise a live cell morphological profiling approach using the xCELLigence RTCA System

The extent to which protein targets are modulated by drugs or small molecule compounds depends on a number of factors, including the expression levels of the target, the effective concentration of the compound, and the time needed for the compound to perturb the target. To address these restrictions, researchers Abassi et al. (1) have devised a live cell morphological profiling approach for dynamic monitoring of the effect of small molecule compounds that was based on impedance measurement of cells with the xCELLigence RTCA System of Roche Applied Science.

27 Aug 2009

Kansas City Cancer Center uses radiation therapy for cancer treatments

Kansas City Cancer Center (KCCC), an affiliate of US Oncology, Inc. which supports the nation's foremost cancer treatment and research network, has treated its first patient with the new TomoTherapy(R) radiation therapy technology at its new KCCC-Shawnee Mission office.

27 Aug 2009

Oncology News and Research

Further Reading

Inhibitor Education Summits to address pertinent topics regarding hemophilia

Research round-up: Highlights from recent releases

Facet Biotech And Trubion to jointly develop and commercialize the TRU-016 SMIP protein therapeutic

Ipsen Group announces first-half 2009 financial results

TRAF6 protein can activate a cell signalling molecule associated with cancer

Springer signs agreement with The Endocrine Society to co-publish a new journal

Gen-Probe commences its PROGENSA PCA3 assay clinical trial

Abbott to partner with Pfizer to develop a companion diagnostic test for non-small cell lung cancer

Dr. David J. Caparrelli becomes a member of SVS at its Vascular Annual Meeting

$11.5 million grant to Mayo Clinic Cancer Center to translate research into treatments for women with ovarian cancer

Novel methodology developed to extract microRNAs from cancer tissues

Gen-Probe commences clinical study to secure U.S. approval of the PROGENSA PCA3 assay

Champions Biotechnology reports higher year-on-year operating revenues for fiscal year 2009

Chk1 and Fbx6 play an important role for the regulation of response to chemotherapy

Arno Therapeutics to commence Phase 1 clinical study of AR-12 in adult patients with lymphoma

Resonant Medical's multi-anatomy Clarity System to be exhibited at ESTRO, Netherlands

Adventist Medical Center receives the Community Value Index Five-Star hospital award

Bioreference Laboratories to issue earnings results for Q3 Fiscal Year 2009

Researchers devise a live cell morphological profiling approach using the xCELLigence RTCA System

Kansas City Cancer Center uses radiation therapy for cancer treatments

Cancer Research eBook

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News